A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis

Shock

Volumn 6, Issue 1, 1996, Pages 46-51

  Morrison, Albert M ^a   Wang, Ping ^a,b,c   Chaudry, Irshad H ^a,b,c,d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTICOAGULANT AGENT; DRUG DERIVATIVE; GLYCERYL TRINITRATE; GM 1892; LOW MOLECULAR WEIGHT HEPARIN; NORADRENALIN;

ANIMAL; AORTA; ARTICLE; CECUM; DRUG EFFECT; IN VITRO STUDY; MALE; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REFERENCE VALUE; SEPSIS; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ANTICOAGULANTS; AORTA; CECUM; ENDOTHELIUM, VASCULAR; HEPARIN, LOW-MOLECULAR-WEIGHT; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SEPSIS; VASOCONSTRICTION; VASODILATION;

EID: 0030184579     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199607000-00010     Document Type: Article

References (41)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
2. Palmer RMJ: The discovery of nitric oxide in the vessel wall: A unifying concept in the pathogenesis of sepsis. Arch Surg 128:396-401, 1993.
3. Myers PR, Wright TF, Tanner MA, Adams HR: EDRF and nitric oxide production in cultured endothelial cells: Direct inhibition by E. coli endotoxin. Am J Physiol 262:H710-H718, 1992.
4. Myers PR, Parker JL, Tanner MA, Adams HR: Effects of cytokines tumor necrosis factor α and interleukin 1β on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium. Shock 1:73-78, 1994.
5. Wang P, Ba ZF, Chaudry IH: Nitric oxide: To block or enhance its production during sepsis? Arch Surg 129:1137-1143, 1994.
6. Wang P, Ba ZF, Chaudry IH: Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis. Am J Physiol 269:R988-R994, 1995.
7. Harbrecht BG, Billiar TR, Stradler J, et al: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukocyte Biol 52:390-394, 1992.
8. G-monomethyl-L-arginine inhibits endothelium-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 48:565-569, 1990.
9. Spain DA, Wilson MA, Garrison RN: Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322-331, 1994.
10. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142-148, 1994.
11. 2 integrin function following acute carbon monoxide poisoning. Toxicol Appl Pharmacol 128:105-110, 1994.
12. Radomski MW, Palmer RMJ, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193-5197, 1990.
13. Lefer AM, Lefer DJ: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 33:71-90, 1993.
14. Tyrrell DJ, Kilfeather S, Page CP: Therapeutic uses of heparin beyond its traditional role as an anticoagulant. Trends Pharmacol Sci 16:198-204, 1995.
15. Wang P, Ba ZF, Chaudry IH: Endothelial cell dysfunction occurs after hemorrhage in nonheparinized but not in preheparinized models. J Surg Res 54:499-506, 1993.
16. Yokokawa K, Tahara H, Kohno M, et al: Heparin regulates endothelin production through endothelium-delivered nitric oxide in human endothelial cells. J Clin Invest 92:2080-2085, 1993.
17. Wang P, Ba ZF, Reich SS, Zhou M, Holme KR, Chaudry IH: Effects of nonanticoagulant heparin on cardiovascular and hepatocellular function after hemorrhagic shock. Am J Physiol 270:H1294-H1302, 1996.
18. Zellweger R, Ayala A, Zhu X-L, Holme KR, DeMaso CM, Chaudry IH: A novel non-anticoagulant heparin improves splenocyte and peritoneal macrophage immune function after trauma-hemorrhage and resuscitation. J Surg Res 59:211-218, 1995.
19. Chaudry IH, Wichterman KA, Baue AE: Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205-211, 1979.
20. Wang P, Ba ZF, Chaudry IH: Increase in hepatic blood flow during early sepsis is due to increased portal blood flow. Am J Physiol 261:R1507-R1512, 1991.
21. Parrillo JE: Septic shock in humans: Clinical evaluation, pathogenesis, and therapeutic approach. In Shoemaker WC, Ayres S, Grenvik A, Holbrook P, Thompson W (eds): Textbook of Critical Care. Philadelphia: W.B. Saunders, 1989, pp 1006-1023.
22. Gimbrone MA Jr, Bevilacqua MP, Cybulsky MI: Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis. Ann NY Acad Sci 598:77-85, 1990.
23. Vanhoutte PM: The endothelium: Modulator of vascular smooth muscle tone. N Engl J Med 319:512-513, 1988.
24. Ignarro LJ: Endothelium-derived nitric oxide: Actions and properties. FASEB J 3:31-36, 1989.
25. Niu X, Smith CW, Kubes P: Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133-1140, 1994.
26. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980.
27. Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: A physiologic messenger. Ann Intern Med 120:227-237, 1994.
28. Morris SM Jr, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:G1004-G1010, 1994.
29. Long CJ, Stone TW: The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels 22:205-208, 1985.
30. Xie QW, Cho HJ, Calaycay J, et al: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1992.
31. Cobb JP, Natanson C, Hoffman WD, et al: N-omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182, 1993.
32. Gianott L, Alexander JW, Pyles T, Fukushima R: Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance: The role of nitric oxide. Ann Surg 217:644-654, 1993.
33. Eddahibi S, Adnot S, Carville C, Blouquit Y, Raffestin B: L-Arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol 263:L194-L200, 1992.
34. Wang P, Singh G, Rana MW, Ba ZF, Chaudry IH: Preheparinization improves organ function after hemorrhage and resuscitation. Am J Physiol 259:R645-R650, 1990.
35. Wang P, Ba ZF, Chaudry IH: Chemically modified heparin improves hepatocellular function, cardiac output, and microcirculation after traumahemorrhage and resuscitation. Surgery 116:169-176, 1994.
36. Voshida M, Tanaka J, Tamura J, et al: Significance of altered fluidity of plasma membranes of the liver and kidney in rats with sepsis. J Surg Res 58:131-136, 1995.
37. Imai T, Hirata Y, Emori T, Marumo F: Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. Hypertension 21:353-358, 1993.
38. Freischlag JA, Colburn MD, Quinones-Baldrich WJ, Moore WS: Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J Surg Res 52:523-529, 1992.
39. Oyanagui Y, Sato S: Heparin, a potent releasing agent of extracellular superoxide dismutase (ECSOD C), suppresses ischaemic paw oedema in mice. Free Radical Res Commun 9:87-99, 1990.
40. Lopez-Ferrer P, Renesto P, Prevost MC, Gounon P, Chignard M: Heparin inhibits neutrophil-induced platelet activation via cathepsin G. J Lab Clin Med 119:231-239, 1992.
41. Lantz M, Thysell H, Nilsson E, Olsson I: On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest 88:2026-2031, 1991.